logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
P

Petra Langerbeins

university of cologne and centre for integrated oncology aachen bonn cologne duesseldorf and excellence centre for medical mycology
H指数:23
被引数:2,418

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effectiveness of an on-site vaccination campaign for patients with cancer

针对癌症患者的现场疫苗接种活动的有效性

BMC Public Health
IF3.6
2026-09-070
OA
Theresa Markus; Sarah Eitze; Ruth Flümann; Philipp Gödel; Michael Hallek; Sebastian Herrmann; Udo Holtick; Jonathan Köllges; Petra Langerbeins; Janina Leckler; Clara Lehmann; Nathalie Lehnen; Ben Mechtel; Johanna Prinz; Tim Richardson; Jan Rybniker; Jon Salmanton-García; Rosanne Sprute; Jonathan Steinke; Jannik Stemler; Thomas Zander; Oliver A. Cornely; Sibylle C. Mellinghoff
Transition Into Clinical Routine and Survival Outcomes of BCL2-and BTK Inhibitors: An Analysis of Patient Data From the GCLLSG Registry

BCL2和BTK抑制剂的临床常规应用及生存结局：一项基于GCLLSG登记数据的患者数据分析

EUROPEAN JOURNAL OF HAEMATOLOGY
IF2.3
2026-08-010
OAAI
Kutsch, Nadine; Ligtvoet, Rudy; Robrecht, Sandra; Linde, Hartmut; Illmer, Thomas; Dorfel, Steffen; Lipke, Jorg; Aldaoud, Ali; Schlag, Rudolf; Dengler, Jolanta; Al-Sawaf, Othman; Langerbeins, Petra; Cramer, Paula; Hallek, Michael; Eichhorst, Barbara; Fischer, Kirsten; Fink, Anna
Ibrutinib in early stage CLL: Genetic risk factors and treatment outcome in the GCLLSG CLL12 trial

伊布替尼在早期CLL中的应用：GCLLSG CLL12试验中的遗传风险因素和治疗结果

Blood
IF23.1
2026-06-220
OA
Armin Riecke; Sandra Robrecht; Deyan Y. Yosifov; Christof Schneider; Adam Giza; Lothar Müller; Ursula Vehling-Kaiser; Michael Eckart; Werner Freier; Björn Schöttker; Tobias Gaska; Marcel Reiser; Anna Fink; Kirsten Fischer; Barbara Eichhorst; Michael Hallek; Petra Langerbeins; Stephan Stilgenbauer; Eugen Tausch
State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop Committee

单克隆B细胞淋巴增多症（MBL）的最新生物学、进展和临床管理：Intercepting Blood Cancers Workshop Committee的共识报告

Blood Cancer Journal
IF11.6
2025-08-290
OAAI
Christine E. Ryan; Inhye E. Ahn; Aswin Sekar; Andrew Rawstron; Julia Almeida; Iñaki Martin-Subero; Erin M. Parry; Miguel Alcoceba; Dinis P. Calado; Alberto Orfao; Anton W. Langerak; Hendrik Veelken; Petra Langerbeins; Deborah M. Stephens; Sameer A. Parikh; Carsten U. Niemann; Sandrine Roulland; Kostas Stamatopoulos; Susan L. Slager; Tait Shanafelt; Paolo Ghia; Jessica Okosun; Matthew S. Davids
MRD-guided zanubrutinib, venetoclax, and obinutuzumab in relapsed CLL: primary end point analysis from the CLL2-BZAG trial

MRD指导下的zanubrutinib、venetoclax和obinutuzumab在复发性CLL中的应用：CLL2-BZAG试验的主要终点分析

BLOOD
IF23.1
2025-01-301
PRE
Fuerstenau, Moritz; Robrecht, Sandra; Schneider, Christof; Tausch, Eugen; Giza, Adam; Ritgen, Matthias; Bittenbring, Joerg; Hebart, Holger; Schoettker, Bjoern; Illert, Anna Lena; Graeven, Ullrich; Stoltefuss, Andrea; Heinrich, Bernhard; Eckert, Robert; Fink, Anna; Stumpf, Janina; Fischer, Kirsten; Al-Sawaf, Othman; Simon, Florian; Kleinert, Fanni; Weiss, Jonathan; Kreuzer, Karl-Anton; Schilhabel, Anke; Brueggemann, Monika; Langerbeins, Petra; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael; Cramer, Paula
Infections in patients with chronic lymphocytic leukemia treated with time limited targeted drug combinations
AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2024-05-170
OAAI
Langerbeins, Petra; Giza, Adam; Robrecht, Sandra; Cramer, Paula; von Tresckow, Julia; Al-Sawaf, Othman; Fink, Anna Maria; Fuerstenau, Moritz; Kater, Arnon; van der Spek, Ellen; Niemann, Carsten Utoft; da Cunha-Bang, Caspar; Tausch, Eugen; Schneider, Christof; Stilgenbauer, Stephan; Fischer, Kirsten; Hallek, Michael; Eichhorst, Barbara
Bendamustine, followed by obinutuzumab and idelalisib in chronic lymphocytic leukemia (CLL2-BCG): Final analysis of a multicenter, open-label phase-II-trial
AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2024-04-050
OAAI
Cramer, Paula; von Tresckow, Julia; Fink, Anna-Maria; Robrecht, Sandra; Giza, Adam; Tausch, Eugen; Mueller, Lothar; Knauf, Wolfgang; Zingerle, Matthias; Al-Sawaf, Othman; Langerbeins, Petra; Fischer, Kirsten; Kreuzer, Karl-Anton; Kneba, Michael; Wendtner, Clemens-Martin; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael
Obinutuzumab, acalabrutinib, and venetoclax, after an optional debulking with bendamustine in relapsed or refractory chronic lymphocytic leukaemia (CLL2-BAAG) a multicentre, open-label, phase 2 trial
LANCET HAEMATOLOGY
IF17.7
2022-10-019
PRE
Cramer, Paula; Furstenau, Moritz; Robrecht, Sandra; Giza, Adam; Zhang, Can; Fink, Anna-Maria; Fischer, Kirsten; Langerbeins, Petra; Al-Sawaf, Othman; Tausch, Eugen; Schneider, Christof; Schetelig, Johannes; Dreger, Peter; Bottcher, Sebastian; Kreuzer, Karl-Anton; Schilhabel, Anke; Ritgen, Matthias; Bruggemann, Monika; Kneba, Michael; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael
Sequential treatment with bendamustine, obinutuzumab (GA101) and Ibrutinib in chronic lymphocytic leukemia (CLL): final results of the CLL2-BIG trial
LEUKEMIA
IF13.4
2022-06-254
OAAI
von Tresckow, Julia; Cramer, Paula; Robrecht, Sandra; Langerbeins, Petra; Fink, Anna-Maria; Al-Sawaf, Othman; Fuerstenau, Moritz; Illmer, Thomas; Klaproth, Holger; Tausch, Eugen; Ritgen, Matthias; Fischer, Kirsten; Wendtner, Clemens-Martin; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Boettcher, Sebastian; Eichhorst, Barbara F.; Hallek, Michael
COVID-19 among fit patients with CLL treated with venetoclax-based combinations
LEUKEMIA
IF13.4
2020-06-2938
OAAI
Fuerstenau, Moritz; Langerbeins, Petra; De Silva, Nisha; Fink, Anna Maria; Robrecht, Sandra; von Tresckow, Julia; Simon, Florian; Hohloch, Karin; Droogendijk, Jolanda; van der Klift, Marjolein; van der Spek, Ellen; Illmer, Thomas; Schoettker, Bjoern; Fischer, Kirsten; Wendtner, Clemens M.; Tausch, Eugen; Stilgenbauer, Stephan; Niemann, Carsten U.; Gregor, Michael; Kater, Arnon P.; Hallek, Michael; Eichhorst, Barbara
Rapid response infrastructure for pandemic preparedness in a tertiary care hospital: lessons learned from the COVID-19 outbreak in Cologne, Germany, February to March 2020
EUROSURVEILLANCE
IF7.8
2020-05-2818
OAAI
Augustin, Max; Schommers, Philipp; Suarez, Isabelle; Koehler, Philipp; Gruell, Henning; Klein, Florian; Maurer, Christian; Langerbeins, Petra; Priesner, Vanessa; Schmidt-Hellerau, Kirsten; Malin, Jakob J.; Stecher, Melanie; Jung, Norma; Wiesmueller, Gerhard; Meissner, Arne; Zweigner, Janine; Langebartels, Georg; Kolibay, Felix; Suarez, Victor; Burst, Volker; Valentin, Philippe; Schedler, Dirk; Cornely, Oliver A.; Hallek, Michael; Faetkenheuer, Gerd; Rybniker, Jan; Lehmann, Clara
Bendamustine followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia: primary endpoint analysis of a multicenter, open-label, phase II trial (CLL2-BIO)
HAEMATOLOGICA
IF7.9
2020-02-2715
OAAI
Cramer, Paula; von Tresckow, Julia; Robrecht, Sandra; Bahlo, Jasmin; Furstenau, Moritz; Langerbeins, Petra; Pflug, Natali; Al-Sawaf, Othman; Heinz, Werner J.; Vehling-Kaiser, Ursula; Durig, Jan; Tausch, Eugen; Hensel, Manfred; Sasse, Stephanie; Fink, Anna-Maria; Fischer, Kirsten; Kreuzer, Karl-Anton; Boettcher, Sebastian; Ritgen, Matthias; Kneba, Michael; Wendtner, Clemens-Martin; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael
Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): a randomized phase 3 trial
LEUKEMIA
IF13.4
2020-02-1855
OAAI
Herling, Carmen D.; Cymbalista, Florence; Gross-Ophoff-Mueller, Carolin; Bahlo, Jasmin; Robrecht, Sandra; Langerbeins, Petra; Fink, Anna-Maria; Al-Sawaf, Othman; Busch, Raymonde; Porcher, Raphael; Cazin, Bruno; Dreyfus, Brigitte; Ibach, Stefan; Lepretre, Stephane; Fischer, Kirsten; Kaiser, Florian; Eichhorst, Barbara; Wentner, Clemens-Martin; Hoechstetter, Manuela A.; Doehner, Hartmut; Leblond, Veronique; Kneba, Michael; Letestu, Remi; Boettcher, Sebastian; Stilgenbauer, Stephan; Hallek, Michael; Levy, Vincent
Influence of obesity and gender on treatment outcomes in patients with chronic lymphocytic leukemia (CLL) undergoing rituximab-based chemoimmunotherapy
LEUKEMIA
IF13.4
2019-11-147
PREAI
Fuerstenau, Moritz; Hopfinger, Georg; Robrecht, Sandra; Fink, Anna-Maria; Al-Sawaf, Othman; Langerbeins, Petra; Cramer, Paula; Von Tresckow, Julia; Maurer, Christian; Kutsch, Nadine; Hoechstetter, Manuela; Dreyling, Martin; Lange, Elisabeth; Kneba, Michael; Stilgenbauer, Stephan; Doehner, Hartmut; Hensel, Manfred; Kiehl, Michael G.; Jaeger, Ulrich; Wendtner, Clemens-Martin; Goede, Valentin; Fischer, Kirsten; von Bergwelt-Baildon, Michael; Eichhorst, Barbara; Hallek, Michael; Theurich, Sebastian
Mode of progression after first line treatment correlates with outcome of chronic lymphocytic leukemia (CLL)
AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2019-07-084
OAAI
Al-Sawaf, Othman; Bazeos, Alexandra; Robrecht, Sandra; Bahlo, Jasmin; Gower, Craig; Fink, Anna-Maria; Tresckow, Julia; Cramer, Paula; Langerbeins, Petra; Kutsch, Nadine; Humphrey, Kathryn; Fingerle-Rowson, Guenter; Stilgenbauer, Stephan; Wendtner, Clemens-Martin; Fischer, Kirsten; Eichhorst, Barbara; Hallek, Michael; Goede, Valentin
CLL2-BIG: sequential treatment with bendamustine, ibrutinib and obinutuzumab (GA101) in chronic lymphocytic leukemia
LEUKEMIA
IF13.4
2018-12-1940
PREAI
von Tresckow, Julia; Cramer, Paula; Bahlo, Jasmin; Robrecht, Sandra; Langerbeins, Petra; Fink, Anna-Maria; Al-Sawaf, Othman; Illmer, Thomas; Klaproth, Holger; Estenfelder, Sven; Ritgen, Matthias; Fischer, Kirsten; Wendtner, Clemens-Martin; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Boettcher, Sebastian; Eichhorst, Barbara F.; Hallek, Michael

研究方向

暂未获取到该数据
M
Michael Hallek
H 指数:124论文数:1,647被引数:7.1万
K
Kirsten Fischer
H 指数:48论文数:389被引数:1.5万
B
Barbara Eichhorst
H 指数:62论文数:439被引数:2.1万
S
Stephan Stilgenbauer
H 指数:126论文数:1,220被引数:7.3万
P
Paula Cramer
H 指数:31论文数:177被引数:6,838
A
Anna‐Maria Fink
H 指数:28论文数:134被引数:3,922
S
Sandra Robrecht
H 指数:30论文数:152被引数:3,817
O
Othman Al‐Sawaf
H 指数:34论文数:184被引数:6,448
J
Julia von Tresckow
H 指数:20论文数:104被引数:2,785
C
Clemens‐Martin Wendtner
H 指数:65论文数:436被引数:2.6万